Inglés

VX-950HPC3006 NCT01571583 Trial Termination

1 formularios  
Trial Completion/Discontinuation
Descripción

Trial Completion/Discontinuation

trial completion/discontinuation
Descripción

please specify if the subject completed the entire course of the follow-up phase of the trial as specified in the protocol or if the subject discontinued the trial early if discontinued pelase specify the primary reason for early termination in the following items

Tipo de datos

integer

Alias
UMLS CUI [1]
C2732579
UMLS CUI [2]
C2718058
adverse event related event, please specify
Descripción

(including death, abnormal lab values, intercurrent illness and pregnancy)

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
Subject lost to follow-up. Date of last contact with subject (visit, call...) in this trial
Descripción

Date of last contact with subject

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0805839
UMLS CUI [1,2]
C0681850
Subject withdrew consent. Date consent withdrawn
Descripción

date consent withdrawn

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
sponsor's decision
Descripción

sponsor's decision

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2347796
UMLS CUI [1,2]
C0679006
other, please specify
Descripción

other reason

Tipo de datos

text

Alias
UMLS CUI [1]
C3840932
did the subject take all investigational medication within the expiry timeframe?
Descripción

investigational medication within expiry timeframe

Tipo de datos

integer

Alias
UMLS CUI [1]
C0013230
Is the subject rolling over to another Tibotec sponsored Trial?
Descripción

subject participation status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
Volver a la parte superior de la página

Similar models

VX-950HPC3006 NCT01571583 Trial Termination

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Trial Completion/Discontinuation
Item
trial completion/discontinuation
integer
C2732579 (UMLS CUI [1])
C2718058 (UMLS CUI [2])
trial completion/discontinuation
Code List
trial completion/discontinuation
CL Item
completed (1)
CL Item
discontinued (2)
adverse event
Item
adverse event related event, please specify
text
C0877248 (UMLS CUI [1])
Date of last contact with subject
Item
Subject lost to follow-up. Date of last contact with subject (visit, call...) in this trial
date
C0805839 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
date consent withdrawn
Item
Subject withdrew consent. Date consent withdrawn
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
sponsor's decision
Item
sponsor's decision
boolean
C2347796 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
other reason
Item
other, please specify
text
C3840932 (UMLS CUI [1])
Item
did the subject take all investigational medication within the expiry timeframe?
integer
C0013230 (UMLS CUI [1])
investigational medication within expiry timeframe
Code List
did the subject take all investigational medication within the expiry timeframe?
CL Item
yes (1)
CL Item
no (2)
CL Item
not applicable (3)
subject participation status
Item
Is the subject rolling over to another Tibotec sponsored Trial?
boolean
C2348568 (UMLS CUI [1])
Volver a la parte superior de la página